Zobrazeno 1 - 10
of 172
pro vyhledávání: '"Govind Babu, K."'
Autor:
Yoshino, T., Cervantes, A., Bando, H., Martinelli, E., Oki, E., Xu, R.-H., Mulansari, N.A., Govind Babu, K., Lee, M.A., Tan, C.K., Cornelio, G., Chong, D.Q., Chen, L.-T., Tanasanvimon, S., Prasongsook, N., Yeh, K.-H., Chua, C., Sacdalan, M.D., Sow (Jenson), W.J., Kim, S.T., Chacko, R.T., Syaiful, R.A., Zhang, S.Z., Curigliano, G., Mishima, S., Nakamura, Y., Ebi, H., Sunakawa, Y., Takahashi, M., Baba, E., Peters, S., Ishioka, C., Pentheroudakis, G.
Publikováno v:
In ESMO Open June 2023 8(3)
Autor:
Suresh Babu MC, Abhishek Anand, Kuntegowdanahalli C. Lakshmaiah, Govind Babu K, Dasappa Lokanatha, Linu Abraham Jacob, DS Madhumathi, Kadabur N Lokesh, AH Rudresha, LK Rajeev, Rajesh Patidar
Publikováno v:
International Journal of Hematology-Oncology and Stem Cell Research, Vol 12, Iss 2 (2018)
Background: T-cell prolymphocytic leukemia (T-PLL) is a rare lymphoid malignancy with dismal prognosis. Most patients have increased lymphocyte count (>1,00,000/dL) and widespread disease at presentation. Despite high response rate seen with alemtuzu
Externí odkaz:
https://doaj.org/article/4546dfbdd74b4703b21b68add4a717e5
Autor:
Vishwanath Sathyanarayanan, Kadabur Nagendrappa Lokesh, Lakshmaiah KC, Govind Babu K, Lokanatha D, Suresh Babu MC, Clementina Rama Rao, Premalata Chennagiri
Publikováno v:
Annals of Saudi Medicine, Vol 34, Iss 6, Pp 551-554 (2014)
Non-Hodgkin lymphoma of the breast is an uncommon entity accounting for approximately 0.5% of malignant breast neoplasms and around 3% of extranodal lymphomas. Most cases of anaplastic large cell lymphoma (ALCL) of the breast have been associated wit
Externí odkaz:
https://doaj.org/article/4be47dff5e754c8fb9a7b5dad5badc84
Publikováno v:
Medical Oncology; Jan2023, Vol. 40 Issue 1, p1-6, 6p
Autor:
Lakshmaiah KC, Vishwanath Sathyanarayanan, Lokesh KN, Premalatha CS, Clementina Rama Rao, Suresh TM, Govind Babu K, Lokanatha D, Linu Abraham Jacob, Umesh Das, Suresh Babu
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 1 (2014)
Background and Purpose: Primary parotid lymphoma (PPL) is an unusual entity and comprises 5% of salivary gland neoplasms and 5% of extra nodal lymphomas. There is limited data in Indian population. Hence we undertook this retrospective observationa
Externí odkaz:
https://doaj.org/article/7df99552127d49ceaebd38ebc81f690d
Autor:
Rohan Bhise, Samit Purohit, Lokanatha D, Linu Jacob, Suresh TM, Govind Babu K, Suresh Babu, Lakshmaiah KC
Publikováno v:
Online Journal of Health & Allied Sciences, Vol 11, Iss 4 (2013)
Objective: To evaluate the efficacy of imatinib in chronic myeloid leukemia patients with variant translocations. Methods: Forty eight chronic myeloid leukemia patients carrying variant translocations and treated with imatinib at our institute were c
Externí odkaz:
https://doaj.org/article/2d0813ae728b46ff98c51d1327f0c0d4
The Complement 1 trial investigated the efficacy and safety of ofatumumab + chlorambucil with chlorambucil monotherapy in patients with previously untreated chronic lymphocytic leukaemia (CLL). On long-term follow-up in the chemoimmunotherapy arm vs.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::6526bad1d480b89e30a40b2625d22ea6
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3120824
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3120824
Next generation sequencing studies in chronic lymphocytic leukemia (CLL) have revealed novel genetic variants that have been associated with disease characteristics and outcome. The aim of this study was to evaluate the prognostic value of recurrent
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______2127::f5e7fd06b49ab24fdbcfd5bd6a8cda0c
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3103839
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3103839
Autor:
Lokesh K N, Rudresh A H, Deepak Koppaka, Rajesh Patidar, Premalata C S, K C Lakshmaiah, Suresh Babu M C, Rajeev L K, Vikas Asati, D. Lokanath, Smitha Saldanha, Linu Abraham Jacob, Govind Babu K
Publikováno v:
European Journal of Haematology. 100:644-648
BACKGROUND During the treatment of diffuse large B-cell lymphoma (DLBCL) patients, treatment-related toxicities are higher in the initial phase of treatment (First cycle effect). Toxicities can be tumor lysis syndrome, deterioration in performance st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5edca8c3e130dd4e67dcf2dd9249167
https://doi.org/10.1111/ejh.13068
https://doi.org/10.1111/ejh.13068
Autor:
Lakshmaiah, K. C.1, Govind Babu, K.1, Dasappa, Loknatha1, Abraham, Linu Jacob1, Suresh Babu, M. C.1, Premalatha, C. S.2, Rao, Clementina Rama2, Rajeev, L. K.1, Rudresha, A. H.1, Lokesh, K. N.1, Rao, Suparna Ajit1, Garg, Sunny1 sunnygarg1987@gmail.com
Publikováno v:
Clinical Cancer Investigation Journal. Jan-Feb2017, Vol. 6 Issue 1, p103-107. 5p.